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BACKGROUND: Genetic variation research (GVR) may
raise concerns about misuse of information and dis-
crimination. Seemingly contradictory positive views
about GVR have also been reported.
OBJECTIVE: To dissect this inconsistency, our objec-
tives were to: (1) explore open-ended views of GVR and
(2) quantify views of and willingness to participate in
GVR by race.
DESIGN: Cross-sectional study.
PARTICIPANTS: 801 African-American and white prior
participants in a case-control genetic epidemiology
study of colon cancer risks (NCCCS).
MEASURES: Qualitative measures evaluated responses
to questions about good and bad things about GVR.
Quantitative measures evaluated positive and negative
perceptions, perceptions of discrimination, and likeli-
hood of future participation by race.
RESULTS: Open-ended queries about GVR resulted in
few “negative” responses. In closed-ended questions,
however, African Americans were more likely to feel that
such research would: result in higher insurance (41%
vs. 30%, p=0.008), not benefit minorities (29% vs. 14%,
p=<0.001), reinforce racism (32% vs. 20%, p=0.002),
and use minorities as guinea pigs (27% vs. 6%, p<
0.001). Overall, after adjustment for potential con-
founding factors, African-American race remained in-
versely associated with feeling “very positive” about
GVR (46% vs. 57%, p=0.035). In contrast, African
Americans were as likely as whites to express willing-
ness to participate in future GVR studies (46%).
CONCLUSIONS: Open-ended questions about GVR
were unlikely to spontaneously generate “negative”
responses. In contrast, when presented specific exam-
ples of potentially negative implications, more respon-
dents agreed, and minorities were more likely to express
concerns. This suggests that while participants appear
generally positive about GVR, their inability to articu-
late views regarding these complex concepts may
require that researchers engage lay audiences, ensure
accurate understanding, and provide them with lan-
guage to express concerns.
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BACKGROUND
Researchers have increasingly focused efforts on genetic
variations research (GVR), research that seeks to understand
genetic differences by racial/ethnic group, often in the hopes of
addressing racial and ethnic diparities. Supporters of such
work suggest that it may lead to improved health for indivi-
duals and populations, proposing that a better understanding
of disease risk and targeted pharmacogenomic innovations are
examples of this potential.1,2 However, others express con-
cern about the lack of clarity and consistency around the
assignment of racial categories, along with fear of increased
bias, discrimination, and reinforced stereotypes that may
shift focus away from important social determinants of
health.3–8 One study, in fact, demonstrated that lay audi-
ences exposed to messages about genetics that are linked to
either ‘Whites’ or ‘Blacks’ were more likely to endorse higher
levels of racism, beliefs about a genetic basis for racism, and
genetic discrimination.4
To date, the bulk of this debate is in the academic arena and
focuses on genetic research in more general terms. Sterling et
al. recently performed a systematic review of studies examin-
ing public opinions on GVR and found only one study that
prompted discussion about research specifically on the rela-
tionships of race, genes, and health.9 Much less is known
about the public perception of this type of investigation. While
relevant cautions and concerns regarding general genetic
testing and research have been elicited from researchers,
minority organizations, and the public,10–15 seemingly contra-
dictory positive views about genetics research have also been
reported.10,15
To dissect this inconsistency, we examined views of GVR
among African-American and white participants in a genetic
epidemiology study, using a mixed method approach – with
both qualitative and quantitative components. We present
findings from this study that evaluate qualitative open-ended
responses to queries of the “good” and “bad” of GVR; quantify
participant positive and negative views of and willingness to
participate in GVR by race; and offer insight and implications
for public discourse about this complex and controversial
topic.
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Learning About Research in North Carolina (LeARN) is a
cross-sectional study of African Americans and whites who
had previously participated in a case-control genetic epide-
miology study of colon cancer risk factors, the North
Carolina Colorectal Cancer Study (NCCCS). In NCCCS,
cases had a diagnosis of invasive colorectal cancer. Controls
were drawn from DMV records and Medicare beneficiary
lists. Race was initially obtained from cancer registry
records and DMV or HCFA files and further confirmed by
self-identification during the interview. When there were
conflicting data, the participants’ self-identified race was
used. We used the NCCCS database to identify participants
interested in participating in other studies. Those who
expressed interest were contacted to take part in the LeARN
telephone interviews. They were eligible to participate if they
met the following criteria (1) self-reported race of African
American or non-Latino white, (2) completed the entire
interview required of NCCCS, (3) agreed to be contacted
about future studies, (4) lived in the state of North Carolina
at the time of the LeARN study, and (5) had sufficient
cognitive functioning, as assessed by the interviewer, to
allow successful completion of the telephone interview.
Recruitment Procedures and Data Collection
Potential participants were mailed a letter by the NCCCS
investigators that introduced the LeARN study, described
the telephone interview, and alerted them to expect a follow-
up telephone call. We contracted with the professional
survey group, FGI, Inc., to conduct the telephone interviews
using Computer Assisted Telephone Interviewing (CATI)
methods. Potential participants were contacted on an aver-
age of 4 months after completing the NCCCS interview.
LeARN interviewers were racially diverse and trained to
address barriers to research participation. We used a
follow-up protocol with at least ten attempts made at
different times of day and different days of the week to
maximize response rates.
Participants provided verbal consent to participate in the
telephone interview. All interviews were audio-taped and
transcribed for content analysis of the open-ended questions.
The final LeARN participant questionnaire took on average 45
min to complete. After completion of the LeARN interview, each
participant was mailed an incentive of $25. All procedures
were approved by both the UNC and Emory University
Institutional Review Boards.
Quantitative Analysis
Views of GVR were assessed by examining the Likert responses
to two questions, “How positive or negative do you feel about
genetic research that looks into why different racial groups get
different diseases?” and “How likely would you be to take part
in such a study in the future?” Because a large majority of
participants answered positively to both these questions, we
dichotomized each response at the highest category, i.e., “Very
positive” versus the other responses for the first question, and
“Very likely” compared to the other responses for the second
question. We examined racial and other participant character-
istics for differences in responses to these two questions using
Pearson’s chi-square tests. In addition, participants were given
a list of five potential concerns about minority participation in
genetic research and were asked whether they agreed or
disagreed with these statements. We used Pearson’s chi-
square tests to examine whether these responses differed by
race. We were particularly interested in racial differences in
responses to views of GVR. To examine this in more depth, we
used logistic regression models to see if any observed differ-
ences remained after adjustment for potential confounding
factors, including concerns about minority participation. We
developed a separate model for each of the two outcomes. Each
initial model included race as our main study factor and the
other participant characteristics as potential confounding
variables (case status, age, gender, education, income, how
religious, health status, family history of cancer, how much
they had heard about GVR, and concerns about minority
participation). We used a “change in effect” elimination strat-
egy to reduce the models. We considered dropping potential
confounders when removing them from the model caused little
change (<10%) in the estimate of the relationship between race
and each outcome. The estimates for the differences between
African Americans and whites were reported as adjusted
percents, based on the beta coefficients from the final logistic
regression models. We chose to report adjusted percents rather
than odds ratios because of the common occurrence of both
outcomes (54% and 45%); odds ratios would over-estimate the
size of the effect.
Qualitative Analysis
Qualitative analysis was performed to more fully understand
the views and responses of participants. Since our original
sample was too large for an in-depth qualitative analysis, a
smaller sub-sample (N=194) was created. We included the first
51 African-American cases and 46 African-American controls.
We then matched participants by case status, age, education,
and sex to an equal number of white cases and controls. Most
of the 97 African-American participants had only one clear
match among the white participants. In cases where there was
more than one potential match, a match was randomly
chosen.
For this sub-sample of 194, we analyzed qualitatively
responses to four open-ended questions, (1) “What are the
good things for yourself and your family about participating in
genetic research that looks at why different racial groups get
different diseases;” (2) “what are the good things for society
about participating in genetic research that looks at why
different racial groups get different diseases?” These two
questions were then repeated for a list of the “bad things.”
Codes were initially developed by the team of LeARN investi-
gators, applied, and validated through an iterative process.
Two coders applied the codes to all responses to open-ended
questions; periodic checks were undertaken to assure unifor-
mity of application. Four LeARN investigators worked to
further refine and validate codes for the four questions used
in this paper. Additionally, there was a final review of each of
the transcripts by race to determine if African Americans and
whites articulated their responses differently even when coded
similarly.
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RESULTS
Participant Characteristics
The overall response rate for the LeARN study was 73%. This
represents the percent of NCCCS participants who were
eligible for LeARN and responded to our survey. There were
801 respondents in the sample, of which 153 were African
Americans (19%). The mean age was 64.3 years (SD=9.90).
Cases from NCCCS made up 55% of the LeARN sample, 57%
were male, and most had at least a high school education
(Table 1). African Americans and whites were comparable in
age and reported similar perceived health status. African
Americans, however, were somewhat more likely than whites
to have been cases in the NCCCS study (55% of African
Americans vs. 43% of whites; p=0.008), to be female (51% vs.
41%, p=0.026), to report less education (31% vs. 11% had less
than high school), to have lower income (48% vs. 15% made
less than $20,000), to be more religious (64% vs. 51% were
very religious), and to have heard more about GVR (29% vs.
16% heard “a lot”). A large majority of both African Americans
and whites felt positive about GVR (84% and 93%), although
African Americans were less likely to feel very positive (43% vs.
56%). Both groups expressed that they would be very likely or
somewhat likely to participate in future studies (82% and
87%), and these responses did not differ by race.
Qualitative Analysis
In the qualitative analysis, several themes emerged. Respon-
dents were positive about the potential for GVR to contrib-
ute to knowledge, determine causes, prevent, and find the
cures for diseases. Some felt that GVR might help determine
differential group risk and identify culturally/racially specif-
ic lifestyle risks. One said, “Different groups have different
lifestyles, they eat different, they do things different, and, of
course, some ethnic groups are more prone to diseases,
such as diabetes and high blood pressure.” Others dis-
cussed equity in research and felt it would allow researchers
to prioritize research on certain groups to address prior
inequalities. For example, “Well, it would benefit the racial
groups who have not been targeted before.” “It’s like giving
everyone the same starting block… Making sure that
everyone has the same advantage.”
Some people discussed dispelling racial myths through
research as one potential positive consequence. “A good
thing would be to give you honest answers … There are
certain myths and many perhaps untruths about genetic
passing down. I feel very strongly that there are too many
myths about it, and I believe this would expose and expel
some of it.” “You create a better understanding among all
people. Then what you do if the research is genuine… you
eliminate the greater chance of discrimination. Because you
have actual facts.”
In contrast, some respondents disagreed with the premise of
race as the central issue. While the frequencies of these
qualitative responses coded as “race is not the issue” did not
vary by race, African Americans and whites articulated their
responses differently in some cases. Whites in several cases
reported that we are all the same, should be treated equally,
and such distinctions should not be made. For example, “I feel
like everybody’s created equal.” ‘It doesn’t make any difference
the race… I know that scientists want to separate the racial
groups… I don’t know.” “To me a man’s a man whether
regardless of his race… I think we’re all one people even
though African American, white, red, yellow, whatever.”
While African Americans expressed similar views of equality,
they also offered alternatives to race as grounds for disease
disparities. Examples such as money, health care, and food
were offered as more relevant issues than race. One person
stated, “I don’t think it has to do with race itself. I think it has
to do with your access to proper foods and proper medical
Table 1. Participant Characteristics, Overall and by African











Case status in NCCCS
Case 45 55 43 0.008
Control 55 45 57
Age
40 to 54 years 20 21 20 0.662
55 to 69 years 42 44 42
70 to 85 years 38 35 38
Gender
Male 57 49 59 0.026
Female 43 51 41
Education
Less than high school 15 31 11 <0.001
High school graduate 25 28 24





Less than $20,000 21 48 15 <0.001
$20,000 to $40,000 27 26 26
More than $40,000 52 26 59
How religious
Not religious 5 4 5 0.001
Somewhat religious 42 32 44
Very religious 53 64 51
Perceived health status
Excellent 13 13 13 0.113
Very good 37 30 39
Good 30 32 29
Fair 14 20 13
Poor 6 5 6
Cancer Hx
Case, family hx (relative) 6 8 6 0.027
Case, no family hx
(relative)
39 47 37
Control, family hx (self
or relative)
18 11 20
Control, no family hx
(self or relative)
37 34 37
How much heard about genetic research and race
A lot 18 29 16 0.001
Little 71 59 73
None 11 12 11
How positive about genetic research about racial differences
Very positive 54 43 56 <0.001
Positive 37 41 37
Neutral or negative 9 16 7
How likely to take part in genetic research about racial differences
Very likely 45 44 45 0.284
Somewhat likely 41 38 42
Neutral or unlikely 14 18 13
*Percents are column percents, e.g., 55% of African Americans are cases
and 43% of whites are cases
†p value for chi-square test comparing each characteristic to African
Americans vs. whites
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attention more so than race. But I don’t think it has to with the
genetic makeup of those races.” One respondent stated, “Uh, I
think as being African American... that if we had the resources
like money and good health-care provider we wouldn’t have the
genetic diseases like we would because we would know more
about taking care of ourselves.” Finally, one respondent
explicitly offered bias as a cause. “And there are certain
diseases that African Americans get that whites don’t and it
could be because of prejudice.”
Few voiced concerns about the negatives of GVR. The
respondents who did raised issues of abuse of information (“If
this information was used against you for employment pur-
poses or being able to get insurance coverage”); discrimination
(“Whatever racial group had a particularly strong indication of
a particular problem that may be discriminated against
because of it"); stereotyping (“Sometimes people are stereo-
typed that they’re bad because of the fact that maybe this race
is affected by a certain disease more so than others”); and
increased anxiety (“The only thing is knowing ahead of time
that you’re going to catch something or get something
terrible”).
Finally, when our sample of respondents who had partici-
pated in a study collecting genetic data were asked open-ended
questions about the positives or negative about GVR, many
expressed limited knowledge. When asked about the positives
and negatives of GVR for themselves, their family and society,
20% reported “did not know” of any positives/negatives.
Similarly, 10% of the sample said they did not understand
these questions or responded in a manner that made us doubt
their comprehension.
Quantitative Analysis
In contrast to our open-ended questions, in which many were
unable to articulate either general responses or specific
negatives, when given a list of potential implications of
research that collects information about genes, most were able
to articulate concerns in response to closed-ended questions.
African Americans were more likely than whites to feel that
such research would: result in higher insurance premiums
(41% vs. 30%, p=0.008), not benefit minorities (29% vs. 14%,
p=<0.001), reinforce racism (32% vs. 20%, p=0.002), and use
minorities as guinea pigs (27% vs. 6%, p<0.001) (Table 2).
African-American controls were the most likely to express
concerns about minorities’ participation in genetic research
when compared to African-American cases, white cases, and
white controls.
Overall, African Americans were less likely than whites to
feel very positive about GVR (43% vs. 56%; p=0.003) (Table 3).
Other participant characteristics associated with feeling very
positive about GVR were older age, male gender, more
education, higher income, not being religious, better perceived
health status, having heard more about GVR, and disagreeing
that minorities are used as guinea pigs. When we included
these other factors in a logistic regression model, they had a
neglible effect on the relationship between race and feeling very
positive. Even after adjustment, African-American race
remained inversely associated with feeling “very positive” about
genetic research (46% AA vs. 57% white, p=0.035). In contrast,
in both the bivariate analysis and in the logistic regression
model adjusting for potential confounding variables, African
Americans were as likely as whites to express willingness to
participate in future studies “that look at why different racial
groups get different diseases” (45% for both groups in the
bivariate analysis; 46% for both groups in the logistic regres-
sion model).
DISCUSSION
Our research indicates that the majority of participants in a
genetic epidemiology study of colorectal cancer in North
Carolina were generally positive about GVR. In fact, when
asked open-ended questions about their views of GVR, parti-
cipants were unlikely to spontaneously generate “negative”
responses. Additionally, despite having previously participated
in genetic research that examined differences in genetic and
other risk factors by race (NCCCS), a surprising number
reported having no knowledge of GVR or did not understand
the question. In contrast, when presented with specific
examples of potentially negative implications of such research,
more respondents endorsed these views, and minorities were
significantly more likely to express concerns.
Broad views on GVR among a diverse study sample should
not be unexpected given the complexity of this material. Our
sample of prior participants in a genetic study expressed views
that demonstrate both remarkable insight as well as limited
understanding in some cases. Participants were often affirma-
tive and optimistic on the one hand yet guarded on the other.
These differing responses seem inconsistent, but may instead
characterize multifaceted and emerging views on this chal-
lenging topic. The inability to freely articulate responses to
open-ended queries, even among those that have previously
participated in genetic research, points to the difficulty lay
audiences may have communicating the concepts and lan-
guage of genetic research. The complexity of genetic concepts
for lay audiences has been corroborated in prior survey
research that found that very few respondents (11%) consid-
ered themselves “very informed” about scientific discoveries. In
this survey, 48% had not heard of the Human Genome
Project.16 Conversely, other researchers have demonstrated
that the public is capable of articulating complex views of
genetic research irrespective of advanced education or course-
work.10,17 Importantly, our work suggests that the content of
questions and method of inquiry may also play a role in the
responses generated.














% Minorities less likely to
benefit
29 14 <0.001
% Research could reinforce
racism
32 20 0.002
% Minorities used as guinea
pigs
27 6 <0.001
*P value for chi-square test comparing race (African Americans vs.
whites) to each concern about minority participation question
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In addition to the complexity of the subject matter by itself,
wide-ranging individual perspectives—shaped by experiences,
media, and other cultural influences—have also been reported.
Prior research suggests that the public is positive about the
potential of genetic research to contribute to improved
health.10,11,15 Our work parallels prior findings that these
generally optimistic public perceptions are often multifaceted,
nuanced, and may not be equally expressed by all groups.10
Earlier studies of lay perceptions of genetic research have
demonstrated increased concerns among minorities regarding
potential loss of privacy, genetic discrimination, and potential-
ly undesirable or dangerous genetic research.12,18 African
Americans’ negative views are often considered in the context
of a historical legacy of discrimination often based on the
assertion of genetic inferiority as well as government-funded
research, such as the Tuskegee study.19 Even so, African
Americans and whites generally share similar optimism re-
garding the promise of genetic research.10,15,18,20
Limitations
This study does have limitations that should be noted. First,
while the overall NCCCS sample is large, it still represents one
state; regional variations may limit generalizability. Next, we
chose to examine African-American and white views only. It is
likely that other groups may have differing concerns and views.
This sample represents the opinions of subjects that had
previously participated in genetic research. Their willingness
to participate in at least two research projects (NCCCS and
LeARN) suggests an openness to genetic research that, per-
haps, would exceed that of the general population. Addition-
ally, while the LeARN response rate was quite good (73%), there
are biases inherent in the sample that further limit its
generalizability. The response rate differed by race: 65% of
African Americans participated compared to 75% of whites. It
is likely that African Americans who agreed to participate in
LeARN were more likely to feel positive toward genetic research
then those who did not agree to participate. Differences
between African Americans and whites about how positive
they felt about genetic research conceivably could have been
larger than we observed had we had been able to recruit both
races equally. Even so, the difference between these groups in
LeARN was still statistically significant.
Implicatons/Future Research
Despite these limitations, a number of relevant themes and
information emerged that may have implications and add
direction to future work in this area. The aforementioned
discussions of genetic research in general terms has generated
complex opinions from lay audiences.20,21 As greater attention
is focused on population-specific genetic variation research,
additional questions will emerge about the application and
implications of the results of this work. Given historical
abuses18 and concerns about collective risks, such as disease
associations, stigmatization, and discrimination for socially
identifiable groups,22 explorations of lay perceptions of
population-specific genetic variation are likely to heighten
this complexity. As funding and eventually treatment and
clinical practice recommendations are considered, assessing
the public’s and particularly minority groups’ concerns, fears,
and perceptions of GVR is critically important.
Table 3. Bivariate Comparisons of Participant Characteristics and
Percent “Very Positive” About GVR, and Percent “Very Likely” to

















African American 43 0.003 45 0.942
White 56 45
Case status in NCCCS
Case 51 0.171 41 0.068
Control 56 48
Age
40 to 54 42 0.006 41 0.142
55 to 69 60 49
70 to 85 58 42
Gender
Male 57 0.037 48 0.043
Female 50 41
Education
Less than high school 42 <0.001 40 0.065








Less than $20,000 48 0.009 36 0.014
$20,000 to $40,000 50 50
More than $40,000 61 49
How religious
Not religious 65 0.028 63 0.002
Somewhat religious 49 38
Very religious 58 49
Perceived health status
Excellent 67 0.028 54 0.105







43 0.325 37 0.223






Control, no family hx
(self or relative)
56 47
How much heard about genetic research and race (GVR)




Agree 55 0.555 43 0.429
Disagree 53 46
Higher insurance to minorities
Agree 54 0.966 43 0.515
Disagree 54 46
Minorities less likely to benefit
Agree 55 0.687 40 0.188
Disagree 53 46
Research could reinforce racism
Agree 53 0.848 44 0.876
Disagree 54 45
Minorities used as guinea pigs
Agree 38 0.003 36 0.110
Disagree 56 46
*P value for chi-square tests comparing each characteristic to each
outcome
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Given the paucity of literature examining lay perceptions of
GVR, this work, demonstrating wide-ranging views within one
diverse study population, begins to lay the foundation for
further investigation of public perceptions. Importantly, it
suggests that ongoing queries of opinions of GVR are likely to
generate diverse, occasionally conflicting views that should be
expected, accounted for, and explored. To that end, unidimen-
sional research models may become increasingly inadequate.
Rather, research models should utilize a range of approaches
and be communicated in a variety of forums. Approaches that
combine quantitative and qualitative responses can be
expected to enhance researchers’ understanding of public
opinion regarding risks and benefits of GVR — the former
allowing a deeper canvasing of public perceptions in their own
words and the latter providing them with the language to
express their concerns.
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